23499-01-6 Usage
Description
4-Piperidinone, 1-(4-nitrophenyl)is a chemical compound with the molecular formula C11H13N3O3. It is a nitrophenyl derivative of piperidinone, characterized by its pale yellow crystalline solid appearance. 4-Piperidinone, 1-(4-nitrophenyl)has a melting point of 99-101°C and a boiling point of 378.5°C. Due to its irritant properties to the skin, eyes, and respiratory system, it requires careful handling and proper storage to prevent decomposition and degradation from exposure to moisture or extreme temperatures.
Uses
Used in Pharmaceutical Industry:
4-Piperidinone, 1-(4-nitrophenyl)is utilized as an intermediate in the synthesis of various pharmaceuticals and chemicals. Its role in the production process is crucial for creating a range of medications and other chemical products that serve different therapeutic and industrial purposes.
Check Digit Verification of cas no
The CAS Registry Mumber 23499-01-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,3,4,9 and 9 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 23499-01:
(7*2)+(6*3)+(5*4)+(4*9)+(3*9)+(2*0)+(1*1)=116
116 % 10 = 6
So 23499-01-6 is a valid CAS Registry Number.
23499-01-6Relevant articles and documents
BRAF DEGRADERS
-
Page/Page column 155-156, (2022/02/06)
Present invention provides compounds that cause specifically the degradation of BRAF. The present compounds are useful for the treatment of various cancers.
2,4-dibasic miazines compound
-
, (2017/08/29)
The invention belongs to the field of medical chemistry, relates to a 2,4-dibasic miazines compound and specifically relates to a compound shown as formula (I) or a pharmaceutically acceptable salt thereof, a drug compound thereof and an application thereof in treating EGFR or/and ALK mediated diseases.
PHENYL AMINO PYRIMIDINE BICYCLIC COMPOUNDS AND USES THEREOF
-
, (2014/01/17)
The present invention relates to phenyl amino pyrimidine bicyclic compounds formula (I) which are inhibitors of protein kinases including JAK kinases. In particular the compounds are active against JAK1, JAK2, JAK3 and TYK2 kinases. The kinase inhibitors can be used in the treatment of kinase associated diseases such as immunological and inflammatory diseases including organ transplants; hyperproliferative diseases including cancer and myeloproliferative diseases; viral diseases; metabolic diseases; and vascular diseases.